[Arrhythmogenic left ventricular cardiomyopathy: beyond magnetic resonance imaging]

Arrhythmogenic left ventricular cardiomyopathy: beyond magnetic resonance imagin

Cardiac Computed Tomography in Monitoring Revascularization

The use of coronary computed tomography angiography (CCTA) in the setting of stable coronary artery disease is highly recommended for low-risk patients. High-risk patients, such as symptomatic subjects with prior revascularization, are suggested to be investigated with noninvasive functional tests or invasive coronary angiography. CCTA is not considered for these patients because of some well-known CCTA artifacts, such as blooming and motion artifacts. However, new technology has allowed us to obtain images with high spatial resolution, overcoming these well-known limitations of CCTA. Furthermore, the introduction of CT-derived fractional flow reserve and stress CT perfusion has made CCTA a comprehensive examination, including anatomical and functional assessments of coronary plaques. Additionally, CCTA allows for plaque characterization, which has become a cornerstone for the optimization of medical therapy, which is not possible with functional tests. Recent evidence has suggested that CCTA could be used with the aim of monitoring revascularization, both after coronary bypass grafts and percutaneous coronary intervention. With this background information, CCTA can also be considered the exam of choice in subjects with a history of revascularization. The availability of a noninvasive anatomic test for patients with previous coronary revascularization and its possible association with functional assessments in a single exam could play a key role in the follow-up management of these subjects, especially considering the rate of false-positive and negative results of noninvasive functional tests. The present review summarizes the main evidence about CCTA and coronary artery bypass grafts, complex percutaneous coronary intervention, and bioresorbable stent implantation

EL DERECHO A LA INTERRUPCIÓN LEGAL DEL EMBARAZO: ESTUDIO DIAGNÓSTICO Y DE CAPACITACIÓN A PROFESIONALES SALUD

La presente investigación tuvo como objetivo caracterizar los conocimientos y opiniones de las y los profesionales de salud del Municipio de Avellaneda en relación a la interrupción legal del embarazo (ILE) y a la Interrupción Voluntaria del embarazo (IVE). El estudio tuvo un diseño transversal exploratorio-descriptivo, resultado del análisis de encuestas administradas a una muestra no probabilística de 45 profesionales de la salud del Municipio de Avellaneda. Los resultados se asociaron a los obtenidos en investigaciones anteriores realizadas en el año 2016.  Considerando este relevamiento previo y los sucesos que acontecieron entre ambos períodos, se pudo caracterizar un mayor conocimiento y adhesión de la práctica de la ILE por parte de las y los profesionales de salud, así como un mayor acuerdo con la IVE

Multi-domain lifestyle intervention in older adults after myocardial infarction: rationale and design of the PIpELINe randomized clinical trial

BackgroundTraditional cardiac rehabilitation (CR) is effective in improving physical performance and prognosis after myocardial infarction (MI). Anyway, it is not consistently recommended to older adults, and its attendance rate is low. Previous studies suggested that alternative, early and tailored exercise interventions are feasible and effective in improving physical performance in older MI patients. Anyway, the demonstration that they are associated also with a significant reduction of hard endpoints is lacking.AimTo describe rationale and design of the "Physical activity Intervention in Elderly patients with myocardial Infarction" (PIpELINe) trial.MethodsThe PIpELINe trial is a prospective, randomized, multicentre study with a blinded adjudicated evaluation of the outcomes. Patients aged >= 65 years, admitted to hospital for MI and with a low physical performance one month after discharge, as defined as short physical performance battery (SPPB) value between 4 and 9, will be randomized to a multi-domain lifestyle intervention (including dietary counselling, strict management of cardiovascular and metabolic risk factors, and exercise training) or health education. The primary endpoint is the one-year occurrence of the composite of cardiovascular death or re-hospitalization for cardiovascular causes.ResultsThe recruitment started in March 2020. The estimated sample size is 456 patients. The conclusion of the enrolment is planned for mid-2023. The primary endpoint analysis will be available for the end of 2024.ConclusionsThe PIpELINe trial will show if a multi-domain lifestyle intervention is able to reduce adverse events in older patients with reduced physical performance after hospitalization for MI